Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1992 1
1994 3
1995 1
1996 1
1997 3
1998 1
1999 6
2000 5
2001 8
2002 3
2003 8
2004 3
2005 5
2006 5
2007 6
2008 7
2009 7
2010 10
2011 6
2012 7
2013 5
2014 10
2015 12
2016 7
2017 16
2018 13
2019 8
2020 12
2021 9
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Results by year
Filters applied: . Clear all
Page 1
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
Writing Committee for the COMEBAC Study Group, Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, Gasnier M, Lecoq AL, Meyrignac O, Noel N, Baudry E, Bellin MF, Beurnier A, Choucha W, Corruble E, Dortet L, Hardy-Leger I, Radiguer F, Sportouch S, Verny C, Wyplosz B, Zaidan M, Becquemont L, Montani D, Monnet X. Writing Committee for the COMEBAC Study Group, et al. Among authors: becquemont l. JAMA. 2021 Apr 20;325(15):1525-1534. doi: 10.1001/jama.2021.3331. JAMA. 2021. PMID: 33729425 Free PMC article.
Maladie de Gaucher de type 1 (CYP2D6-éliglustat).
Becquemont L. Becquemont L. Therapie. 2017 Apr;72(2):319-322. doi: 10.1016/j.therap.2016.09.013. Epub 2017 Jan 3. Therapie. 2017. PMID: 28189332 French. No abstract available.
Editorial.
Becquemont L, Picard N, Verstuyft C. Becquemont L, et al. Therapie. 2017 Apr;72(2):173-174. doi: 10.1016/j.therap.2017.01.004. Epub 2017 Jan 30. Therapie. 2017. PMID: 28238399 No abstract available.
Pharmacogenetics of hypersensitivity drug reactions.
Negrini S, Becquemont L. Negrini S, et al. Among authors: becquemont l. Therapie. 2017 Apr;72(2):231-243. doi: 10.1016/j.therap.2016.12.009. Epub 2017 Jan 3. Therapie. 2017. PMID: 28162244 Review.
L'évaluation médico-économique des produits de santé dans le contexte de la loi de financement de la Sécurité sociale pour 2012.
Dervaux B, Baseilhac E, Fagon JY; les participants à la table ronde N°6 de Giens XXVIII :, Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A. Dervaux B, et al. Among authors: becquemont l. Therapie. 2013 Jul-Aug;68(4):253-7. doi: 10.2515/therapie/2013044. Therapie. 2013. PMID: 27392727 French. No abstract available.
Psychiatric Side Effects of Chloroquine.
Gressier F, Verstuyft C, Becquemont L, Falissard B, Corruble E. Gressier F, et al. Among authors: becquemont l. J Clin Psychiatry. 2020 Jul 28;81(5):20l13476. doi: 10.4088/JCP.20l13476. J Clin Psychiatry. 2020. PMID: 32726000 Free article. No abstract available.
[Pharmacogenetics for patient care in France: A discipline that evolves!].
Barin-Le Guellec C, Picard N, Alarcan H, Barreau M, Becquemont L, Quaranta S, Boyer JC, Loriot MA; réseau national de pharmacogénétique (RNPGx). Barin-Le Guellec C, et al. Among authors: becquemont l. Therapie. 2020 Sep-Oct;75(5):459-470. doi: 10.1016/j.therap.2019.09.006. Epub 2019 Oct 30. Therapie. 2020. PMID: 31767126 Review. French.
HLA: a pharmacogenomics success story.
Becquemont L. Becquemont L. Pharmacogenomics. 2010 Mar;11(3):277-81. doi: 10.2217/pgs.10.38. Pharmacogenomics. 2010. PMID: 20235781 Free article. Review. No abstract available.
173 results